Logo - springer
Slogan - springer

Life Sciences | Aims and Scope: Neurotherapeutics

Aims and Scope: Neurotherapeutics

Neurotherapeutics® is the journal of the American Society for Experimental NeuroTherapeutics (ASENT). Each issue provides critical reviews of an important topic relating to the treatment of neurological disorders, written by international authorities. 

The Journal also publishes original research articles in translational neuroscience including descriptions of cutting edge therapies that cross disciplinary lines and represent important contributions to neurotherapeutics for medical practitioners and other researchers in the field.

Neurotherapeutics ® delivers a multidisciplinary perspective on the frontiers of translational neuroscience, provides perspectives on current research and practice, and covers social and ethical as well as scientific issues.

Future Issue Themes

October 2014 - Neurogenetic Disease: Genes, Mechanisms and Future Promise
Guest Editor: William Dauer (University of Michigan)

January 2015 - Alzheimer's Disease Therapies
Guest Editors: Michael Shelanski (Columbia) and Roger Lefort (Columbia)

April 2015 - Motor Neuron Diseases
Guest Editors: Eva Feldman (University of Michigan) and Stacey A. Sakowski (University of Michigan)

July 2015 - Autism
Guest Editors: Jeffrey Neul (UC San Diego) and Mustafa Sahin (Boston Children's Hospital)

October 2015 - Cannabinoids in Neuropsychiatric Disorders
Guest Editors: Orrin Devinsky (NYU), Vincenzo Di Marzo (Insitute of Biomolecular Chemistry of the National Research Council, Italy), Ben Whalley (University of Redding, UK)